We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Recombinant Protein Expression System Reduces Production Costs and Speeds Time to Market

By LabMedica International staff writers
Posted on 06 Oct 2009
Print article
An innovative recombinant protein system overcomes conventional microbial expression difficulties by secreting correctly folded, active proteins directly into the growth media. Breakthrough expression system reduces production costs and speeds time to market.

Ajinomoto AminoScience, LLC (Raleigh, NC,USA) announced the launch of Corynex recombinant protein expression system streamlined , more efficient process to express proteins. "Ajinomoto's innovative Corynex recombinant protein expression system reinforces 50 years of leadership within the fermentation and expression fields,” commented Jack Heaton, president of Ajinomoto AminoScience. "With the debut of our new system, we demonstrate that Ajinomoto is an unrivaled industry leader.”

This advanced technology is Ajinomoto's answer to a recent analysis of biotechnology manufacturing by BioPlan Associates, a biotechnology marketing research firm (Rockville, MD, USA). In the January 2009, the firm released a study that outlines the need for advances in manufacturing. The study describes a "reluctance” by companies to modernize with new technology and methodologies so products can be made "more efficiently and to higher clinical standards.”

"This new process shows Ajinomoto's willingness to invest in scientific efforts to improve expression systems,” said Mr. Heaton. "We have answered the industry's call to develop better technology to meet our customers' needs.”

Ajinomoto, one of the worlds' largest manufacturers of amino acids, was the first company in the world to identify, customize, and market amino acids. The company is the only U.S. manufacturer of cGMP pharmaceutical grade amino acids. Key applications include use in therapeutic pharmaceutical development, cell culture media, parenteral and clinical nutrition, health foods, and food applications.

Ajinomoto AminoScience is a supplier of pharmaceutical grade amino acids. Ajinomoto created the standards that have become the accepted benchmark for the amino acid industry. Since its development, the company has provided a steady supply of high quality amino acids while vigorously pursuing research programs and improving manufacturing processes.

Related Links:

Ajinomoto Amino Science


New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
Flu Test
ID NOW Influenza A & B 2
New
LH ELISA
Luteinizing Hormone ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The AI program analyzes a microscopy image from a tumor biopsy and determines what genes are likely turned on and off in the cells it contains (Photo courtesy of Olivier Gevaert/Stanford Medicine)

AI Tool ‘Sees’ Cancer Gene Signatures in Biopsy Images

To assess the type and severity of cancer, pathologists typically examine thin slices of a tumor biopsy under a microscope. However, to understand the genomic alterations driving the tumor's growth, scientists... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.